Business · 23/04/2024Updated: 10/17/2026 · 1 min read
FDA Withdraws Approval of 23 New Drug Applications from Multiple Applicants
Summary
The Food and Drug Administration (FDA) has withdrawn the approval of 23 new drug applications (NDAs) from multiple applicants, including PAI Holdings, LLC DBA Pharmaceutical Associates, Inc., after the applicants notified the Agency that the drug products were no longer being marketed.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →